Cancer Nanomedicine: From Drug Delivery to Imaging

See allHide authors and affiliations

Science Translational Medicine  18 Dec 2013:
Vol. 5, Issue 216, pp. 216rv4
DOI: 10.1126/scitranslmed.3005872

You are currently viewing the editor's summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Editor's Summary

Nanoformulated drugs, genes, and imaging agents have the opportunity to improve cancer treatment and diagnosis. This Review describes the many approaches to nanomedicine, how they are being tested for cancer therapy and imaging, and what obstacles remain in translation.